ISB has developed a kit for early stage prostate cancer diagnosis in collaboration with Multimedica IRCCS institute. You can find the full paper, published on Frontiers in Endocrinology, here. The pilot study (31 controls, 20 patients with PCa and 20 subjects with benign prostate hyperplasia) has shown very interesting data (sensitivity 90% and specificity 84%). The product validation on a wider patient numeber will start very soon. Thus, we invite the clinical group you to collaborate with us, in a financed project, for product validation.
Contact us if you are interested.